Correlation of a commercial platform's results with post-vaccination SARS-CoV-2 neutralizing antibody response and clinical host factors.

Slotkin, Rebecca; Kyriakides, Tassos C; Kundu, Anupam; Stack, Gary; Sutton, Richard E; Gupta, Shaili

Slotkin, Rebecca; Kyriakides, Tassos C; Kundu, Anupam; Stack, Gary; Sutton, Richard E; Gupta, Shaili.

Afiliação

Slotkin R; Yale School of Medicine, New Haven, Connecticut, United States of America.
Kyriakides TC; Yale School of Medicine, New Haven, Connecticut, United States of America.
Kundu A; Yale Center for Analytical Sciences, Yale School of Public Health, New Haven, Connecticut, United States of America.
Stack G; Veterans Healthcare System of Connecticut, West Haven, Connecticut, United States of America.
Sutton RE; Yale Center for Analytical Sciences, Yale School of Public Health, New Haven, Connecticut, United States of America.
Gupta S; Veterans Healthcare System of Connecticut, West Haven, Connecticut, United States of America.

PLoS One ; 18(8): e0289713, 2023.

Article em En | MEDLINE | ID: mdl-37643190

Assuntos

COVID-19; Adulto; Humanos; Feminino; Adulto Jovem; Pessoa de Meia-Idade; Idoso; Idoso de 80 Anos ou mais; Masculino; COVID-19/prevenção & controle; Vacinas contra COVID-19; SARS-CoV-2; Anticorpos Neutralizantes; Imunoglobulina G

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Guideline / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google